Bristol-Myers Squibb Company (BMY) earnings: date, estimates, results and stock reactions
Next earnings: Q4 FY2026 on 2027-02-04 (expected, before the open). EPS estimate 1.53, revenue estimate 12.66B.
Over the last 12 reports the stock moved 4.5% on average (either way), rising 7 times and falling 5. EPS beat estimates 12 of 12 times; revenue 12 of 12. Close before the report date to the first close after it (two trading sessions, covering before-the-open and after-the-close reports).
| Quarter | Reported | EPS | EPS estimate | EPS surprise | Revenue | Revenue estimate | Stock move |
|---|---|---|---|---|---|---|---|
| Q3 FY2026 | 2026-10-29 | 1.35 | 1.10 | +22.7% | 13.07B | 12.72B | +3.2% |
| Q2 FY2026 | 2026-07-30 | 2.04 | 1.60 | +27.5% | 12.97B | 11.74B | +3.5% |
| Q1 FY2026 | 2026-04-30 | 1.58 | 1.42 | +11.3% | 11.49B | 10.93B | +1.1% |
| Q4 FY2025 | 2026-02-05 | 1.26 | 1.23 | +2.4% | 12.50B | 12.28B | +7.6% |
| Q3 FY2025 | 2025-10-30 | 1.63 | 1.52 | +7.2% | 12.22B | 11.85B | +8.1% |
| Q2 FY2025 | 2025-07-31 | 1.46 | 1.09 | +33.9% | 12.27B | 11.44B | -3.8% |
| Q1 FY2025 | 2025-04-24 | 1.80 | 1.49 | +20.8% | 11.20B | 10.70B | -1.3% |
| Q4 FY2024 | 2025-02-06 | 1.67 | 1.47 | +13.6% | 12.34B | 11.57B | -4.8% |